CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243 | -99.7% | 16,328 | -17.3% | 0.02% | +300.0% |
| Q1 2021 | $90,000 | +9.8% | 19,745 | +38.3% | 0.01% | -33.3% |
| Q4 2020 | $82,000 | -82.0% | 14,276 | -77.4% | 0.01% | -88.5% |
| Q3 2020 | $456,000 | +590.9% | 63,051 | +87.6% | 0.08% | +1200.0% |
| Q4 2019 | $66,000 | -61.6% | 33,607 | +40.1% | 0.01% | -40.0% |
| Q2 2019 | $172,000 | -21.5% | 23,992 | +21.3% | 0.01% | -23.1% |
| Q3 2018 | $219,000 | -3.9% | 19,787 | -20.0% | 0.01% | +8.3% |
| Q4 2017 | $228,000 | +78.1% | 24,735 | +56.2% | 0.01% | +100.0% |
| Q3 2017 | $128,000 | – | 15,836 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |